Radial accEss Crossover for PErcutaneous Coronary Procedures And ouTcome: the REPEAT Study
NCT ID: NCT05340998
Last Updated: 2025-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1357 participants
OBSERVATIONAL
2022-07-15
2025-01-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Verapamil vs Heparin in Transradial Procedures
NCT02454491
PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy
NCT03392948
Recurrent Events After Percutaneous Coronary INterventio for ACS
NCT03675347
EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs
NCT06316128
Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility
NCT05160311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The modality of radial puncture (needle vs cannula), the choice of radial sheath (long vs short; hydrophilic vs non hydrophilic), the type of catheters employed, the use of spasmolytic agents and the choice of secondary vascular access will be left to the operator discretion.
According to the selected secondary access, patients will be divided in two groups: patients with a secondary (or tertiary) wrist access (total wrist Group) and patients with a crossover to femoral (Femoral Group). Patients included in the total wrist group may have a secondary access to the ulnar artery (ipsilateral or contralateral) or to the contralateral radial.
All patients will be checked during the procedure, immediately after and 24 hour post to evaluate possible vascular complications and bleeding.
Patient baseline characteristics, hospital data, comorbid conditions and complications will be recorded in a dedicated electronic case report form.
Exclusion criteria will be: lack of signed informed consent, age \<18 years.
Primary End point of the study is the rate of in-hospital vascular complications and major bleeding in crossover vs non crossover groups.
Secondary End-points are:
* The rate of vascular complications or bleeding in total wrist vs femoral Group.
* The rate of minor bleeding
* Procedure duration
* Fluoroscopy time
* Number of catheters employed
* Differences among operators and Centers
Vascular complications are defined as any vascular damage clinically documented as vessel perforation, arterial-venous fistula, pseudoaneurysm, arterial dissection, retroperitoneal hematoma and compartmental syndrome. Major bleeding complications are defined according to the BARC classification, as BARC 3 (overt bleeding plus a hemoglobin drop \> 3 g/dL; any transfusion with overt bleeding, cardiac tamponade; bleeding requiring surgical intervention for control; bleeding requiring intravenous vasoactive agents and intracranial haemorrhage) and BARC 5 (fatal bleeding).
Minor bleeding is defined as Hematoma larger than 10 cm not requiring medical intervention (Easy III)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crossover Group
Patients with Transradial access failure for percutaneous coronary procedures necessitating vascular crossover
Transradial access for percutaneous coronary procedures
Transradial approach for percutaneous coronary procedures. The modality of radial puncture (needle vs cannula), the choice of radial sheath (long vs short; hydrophilic vs non hydrophilic), the type of catheters employed, the use of spasmolytic agents and the choice of secondary vascular access will be left to the operator discretion
Non Crossover Group
Patients with successful transradial access for percutaneous coronary procedures
Transradial access for percutaneous coronary procedures
Transradial approach for percutaneous coronary procedures. The modality of radial puncture (needle vs cannula), the choice of radial sheath (long vs short; hydrophilic vs non hydrophilic), the type of catheters employed, the use of spasmolytic agents and the choice of secondary vascular access will be left to the operator discretion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transradial access for percutaneous coronary procedures
Transradial approach for percutaneous coronary procedures. The modality of radial puncture (needle vs cannula), the choice of radial sheath (long vs short; hydrophilic vs non hydrophilic), the type of catheters employed, the use of spasmolytic agents and the choice of secondary vascular access will be left to the operator discretion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Sandro Pertini, Roma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alessandro Sciahbasi, MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale di Avezzano
Avezzano, , Italy
Ospedale S. Andrea
Roma, , Italy
Ospedale S. Camillo
Roma, , Italy
Ospedale Sandro Pertini
Roma, , Italy
Ospedale Santo Spirito
Roma, , Italy
Policlinico Agostino Gemelli
Roma, , Italy
Policlinico Umberto I
Roma, , Italy
Ospedale di Sassari
Sassari, , Italy
Ospedale di Teramo
Teramo, , Italy
Ospedale di Trento
Trento, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pertini06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.